SCHEMBL9424316

SCHEMBL9424316

CCc1sc(S(=O)(=O)NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 10/20 0.52
EPHX1 P07099 2/20 0.47
EPHX2 P34913 2/20 0.47
MAPT P10636 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP3A4 P08684 1/20 0.45
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
CA9 Q16790 1/20 0.44
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
SLC6A2 P23975 1/20 0.43
PDE4A P27815 1/20 0.43
ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9424401 0.87 FBP1 (0.53) FBP1MAPTMEN1KMT2AHTT
SCHEMBL9424688 0.86 EPHX1 (0.51) FBP1EPHX1EPHX2MAPTMEN1
SCHEMBL9424554 0.81 EPHX1 (0.49) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL9424699 0.81 EPHX1 (0.48) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL9424703 0.81 EPHX1 (0.48) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL9424579 0.80 EPHX1 (0.53) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL9424863 0.79 MAPT (0.53) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL9424859 0.79 EPHX1 (0.51) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL8762919 0.75 MEN1 (0.57) EPHX1EPHX2MAPTMEN1KMT2A
SCHEMBL9424746 0.73 MAPT (0.71) EPHX1EPHX2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5302724-A Thiophenesulfonylureas; anticarcinogenic agents ELI LILLY AND COMPANY (US) 1994-04-12 US disclosed
EP-0467613-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed